Click to go to DrugInjuryLaw Home

Legal information and news about prescription drug side effects
NuvaRing Case Evaluation Ortho Evra Case Evaluation Fosamax Case Evaluation Avandia Case EvaluationKetek Case Evaluation Zelnorm Case Evaluation Meridia Case Evaluation Zocor Case Evaluation
Vytorin Case EvaluationZetia Case Evaluation Yasmin Case Evaluation Ocella Case EvaluationYAZ Case Evaluation Levaquin Case Evaluation Byetta Case Evaluation Gianvi Case Evaluation

Free Case Evaluation

Bextra Information

What is Bextra?

Bextra® is the name under which Pfizer markets a prescription pain medication generically called valdecoxib. Bextra has been under much scrutiny of late because studies have shown adverse reations with Bextra such as heart attack, stroke, sudden cardiac death, Erythema Multiforme (EM), Stevens-Johnson Syndrome (SJS), and Toxic Epidermal Necrolysis (TEN).

Bextra Can Cause Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)
Cases of Stevens-Johnson syndrome and toxic epidermal necrolysis caused by Bextra use have been reported to the FDA. Stevens-Johnson syndrome -- commonly referred to as Stevens-Johnson or SJS -- and toxic epidermal necrolysis, or TEN, are closely related serious skin reactions.

FDA Orders Pfizer to Withdraw Bextra From Market
Bextra withdrawn due to increased risks of cardiovascular problems such as heart attack and stroke, and potentially life-threatening skin reactions such as Stevens-Johnson Syndrome.

Study Finds Bextra Increases Heart Attack Risk By 50 Percent
February 2005 Study Results Link COX-2 Painkillers Vioxx, Celebrex, and Bextra to Heart Attack and Stroke. In February 2005, WellPoint Inc., the nation's largest provider of health benefits, examined 7,232 patient records of people taking Vioxx, Celebrex, and Bextra, and 629,245 records for patients not taking a COX-2 drug.

California HMO Stops Dispensing Bextra
Kaiser Permanente, a California based HMO, hospital, and health clinic network, has stopped prescribing Bextra for at least six months, or until the FDA and/or manufacturer Pfizer can prove Bextra is safe. Kaiser is the nation's largest not-for-profit healthcare provider, serving 8.5 million people in nine states.

Bextra May Get Black Box Warning
In 2002, Pfizer announced in a Dear Doctor letter to health professionals that Bextra can cause a potentially life threatening drug reaction called Stevens-Johnson Syndrome. More recently, Pfizer said that the FDA may require them to put a Black Box warning on the drug's label to alert patients about the Stevens-Johnson Syndrome risk associated with the use of Bextra.

Study Reveals Bextra Doubles Heart Attack Risk
Patients taking Bextra in drug trials were twice as likely to have a heart attack or stroke. Study showed Bextra, an arthritis drug in the COX-2 inhibitor class, is not so different from Vioxx for heart risk.

Bextra Class Actions
Our law firm believes that people injured by Bextra are better served by having an individual lawsuit filed instead of joining a class action lawsuit.

Bextra and Legal Compensation
How to get legal compensation for a Bextra injury or Bextra death.

Bextra Case Evaluation
The information you provide to us for this Free Case Evaluation will be treated as strictly confidential.  You will get a reply from us no later than the next business day.  Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit.  We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.

Drug Injury Watch: Bextra News Commentary

  • US FDA advises that you should not stop taking any prescription medication before talking to your doctor.
  • Reports of serious drug side effects should be made to the US FDA MedWatch program.
  • The prescription drug names are registered trademarks of the respective drug companies.
  • is not affiliated with any of the drug companies, nor US FDA.
Law Offices of Thomas J. Lamb, P.A.
Lumina Station Suite 225
1908 Eastwood Road
Wilmington, NC 28403
Tel: (910) 256-2971   Fax: (910) 256-2972
Toll Free: (800) 426-9535